Clinical Trial Update: Studying DNA and Outcome in Patients With Advanced Colorectal Cancer Treated With Fluorouracil and Oxaliplatin With or Without Bevacizumab on Clinial Trial E-3200

View source ↗

Summary

This completed Phase III trial (E-3200) studied adding bevacizumab to FOLFOX chemotherapy in advanced/metastatic colorectal cancer. The update reports on patien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Bevacizumab (bevacizumab)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: ECOG-ACRIN Cancer Research Group | Conditions: Colorectal Cancer | Status: COMPLETED